“…Adenoid basal cell carcinoma is rare, with an incidence of just 1.3%. 2 Although ABCC is branded with low recurrence risk, it is not mentioned in the latest guidelines. 1,4 Comparing ABCCs with the BCC cohort, comprising both low and high-risk variants, nonsignificant characteristics were identified, apart from the size and recurrence rate.…”